Terms: = Germ cell tumor AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
33 results:
1. Real-World Evaluation of the Management, treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Marcon IG; Valsecchi D; Durso L; Premoli E; Sangiorgi D; Perrone V; Catena L; Degli Esposti L
Adv Ther; 2023 Sep; 40(9):3875-3895. PubMed ID: 37368101
[TBL] [Abstract] [Full Text] [Related]
2. The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma.
Poizeau F; Balusson F; Lemaitre F; Tron C; Pracht M; Russo D; Dinulescu M; Lesimple T; Oger E; Dupuy A
Br J Dermatol; 2023 Mar; 188(4):482-490. PubMed ID: 36760148
[TBL] [Abstract] [Full Text] [Related]
3. Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma.
Jeon H; Byun J; Kang H; Kim K; Lee E; Kim JH; Hong CK; Song SW; Kim YH; Chong S; Kim JH; Nam SJ; Park JE; Lee S
J Transl Med; 2023 Feb; 21(1):69. PubMed ID: 36732815
[TBL] [Abstract] [Full Text] [Related]
4. Inherited germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Pietzak EJ; Whiting K; Srinivasan P; Bandlamudi C; Khurram A; Joseph V; Walasek A; Bochner E; Clinton T; Almassi N; Truong H; de Jesus Escano MR; Wiseman M; Mandelker D; Kemel Y; Zhang L; Walsh MF; Cadoo KA; Coleman JA; Al-Ahmadie H; Rosenberg JE; Iyer GV; Solit DB; Ostrovnaya I; Offit K; Robson ME; Stadler ZK; Berger MF; Bajorin DF; Carlo M; Bochner BH
Clin Cancer Res; 2022 Oct; 28(19):4267-4277. PubMed ID: 35833951
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract] [Full Text] [Related]
6. Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit.
Agrawal R; Goel V; Anand A; Arora RS
Pediatr Blood Cancer; 2022 Feb; 69(2):e29462. PubMed ID: 34842336
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological characteristics, prognostic factors and treatment outcomes of seminomatous germ cell tumours from a tertiary cancer centre in eastern India.
Dabkara D; Ganguly S; Ghosh J; Mukherjee S; Gupta S; Mallick I; Mukherjee S; Midha D; Chatterjee M; Basu A; Hasan A; Biswas B
Natl Med J India; 2021; 34(2):68-72. PubMed ID: 34599114
[TBL] [Abstract] [Full Text] [Related]
8. Network pharmacological mechanism of Cinobufotalin against glioma.
Li C; Guo H; Wang C; Zhan W; Tan Q; Xie C; Sharma A; Sharma HS; Chen L; Zhang Z
Prog Brain Res; 2021; 265():119-137. PubMed ID: 34560920
[TBL] [Abstract] [Full Text] [Related]
9. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
Front Immunol; 2021; 12():629519. PubMed ID: 33746966
[TBL] [Abstract] [Full Text] [Related]
10. Clinical effects of morning and afternoon radiotherapy on high-grade gliomas.
Sapienza LG; Nasra K; Berry R; Danesh L; Little T; Abu-Isa E
Chronobiol Int; 2021 May; 38(5):732-741. PubMed ID: 33557650
[TBL] [Abstract] [Full Text] [Related]
11. Identification of prognostic alternative splicing signatures in uveal melanoma.
Xie X; Zheng X; Xie T; Cai J; Yao Y
Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Characterization of Appendiceal Goblet cell Carcinoid.
Arai H; Baca Y; Battaglin F; Kawanishi N; Wang J; Soni S; Zhang W; Millstein J; Johnston C; Goldberg RM; Philip PA; Seeber A; Xiu J; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ
Mol Cancer Ther; 2020 Dec; 19(12):2634-2640. PubMed ID: 33037134
[TBL] [Abstract] [Full Text] [Related]
13. Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients.
Wick W; Krendyukov A; Junge K; Höger T; Fricke H
J Neurooncol; 2019 Dec; 145(3):531-540. PubMed ID: 31679112
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of Real-World treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine tumors.
Huynh L; Cai B; Cheng M; Lax A; Lejeune D; Duh MS; Kim MK
Pancreas; 2019 Oct; 48(9):1126-1135. PubMed ID: 31593022
[TBL] [Abstract] [Full Text] [Related]
15. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine tumors Treated With
Strosberg J; Wolin E; Chasen B; Kulke M; Bushnell D; Caplin M; Baum RP; Kunz P; Hobday T; Hendifar A; Oberg K; Sierra ML; Thevenet T; Margalet I; Ruszniewski P; Krenning E;
J Clin Oncol; 2018 Sep; 36(25):2578-2584. PubMed ID: 29878866
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Relevance of treatment Failure Patterns in Pediatric High-Grade Glioma: Is There a Role for a Revised Failure Classification System?
Lucas JT; Cooper DA; Hwang S; Tinkle C; Li X; Li Y; Orr B; Merchant TE; Broniscer A
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):450-458. PubMed ID: 28871996
[TBL] [Abstract] [Full Text] [Related]
17. The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.
Trubicka J; Żemojtel T; Hecht J; Falana K; Piekutowska-Abramczuk D; Płoski R; Perek-Polnik M; Drogosiewicz M; Grajkowska W; Ciara E; Moszczyńska E; Dembowska-Bagińska B; Perek D; Chrzanowska KH; Krajewska-Walasek M; Łastowska M
BMC Cancer; 2017 Apr; 17(1):239. PubMed ID: 28376765
[TBL] [Abstract] [Full Text] [Related]
18. Exploratory analysis of ercc2 DNA methylation in survival among pediatric medulloblastoma patients.
Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
[TBL] [Abstract] [Full Text] [Related]
19. Alternatives to surgical approach for giant spinal schwannomas.
Onen MR; Simsek M; Naderi S
Neurosciences (Riyadh); 2016 Jan; 21(1):30-6. PubMed ID: 26818164
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract] [Full Text] [Related]
[Next]
